Apellis Pharmaceuticals (APLS) Profit Margin (2020 - 2026)
Apellis Pharmaceuticals (APLS) profit margin from Sep 30, 2020 to Mar 31, 2026. The current Apellis Pharmaceuticals (APLS) profit margin is 6.95%. You can export chart.
All data is split-adjusted. You can find the most accurate data from the reports on the SEC official website. We recommend verify information using official company filings before making investment decisions.
Annual Profit Margin
Quarterly Profit Margin
Annual Profit Margin change of Apellis Pharmaceuticals (APLS)
| Year | Profit Margin | Change |
|---|---|---|
| 2025 | 2.23% | -108.81% |
| 2024 | -25.32% | -81.00% |
| 2023 | -133.29% | N/A |
| 2023 | -133.29% | -84.59% |
| 2022 | -864.72% | N/A |
| 2022 | -864.72% | -22.88% |
| 2021 | -1121.32% | N/A |
| 2021 | -1121.32% | +714.97% |
| 2020 | -137.59% | N/A |
Comparison Apellis Pharmaceuticals (APLS) profit margin with competitors
Apellis Pharmaceuticals (APLS) profit margin is 6.95%.